^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BZD1901
i
Other names: BZD1901, αPD1-MSLN-CAR T Cells, autologous mesothelin (MSLN)-targeted chimeric antigen receptor (MSLN-CAR) T cells secreting PD-1 nanobodies, autologous PD-1 antibody expressing mesothelin-targeted CAR-Tcells, PD-1 antibody expressing mesoCAR-T cells, αPD-1-mesoCAR-T, BZDS1901
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Shanghai Cell Therapy Group
Drug class:
PD1 inhibitor, Mesothelin-targeted CAR-T immunotherapy
Related drugs:
